Brain disorder mechanisms and therapeutic targets identified from developmental, cell-specific gene regulation
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Genetic variation influences brain physiology and disease across cell types and development. We integrated whole-genome sequencing, bulk RNA sequencing, and single-nucleus multiome profiling from 231 human dorsolateral prefrontal cortex donors spanning six postconceptional weeks to 92 years. Across 24 brain-related traits, neurodevelopmental and psychiatric genetic risk was enriched in neuronal transcriptomic and chromatin profiles, whereas neurodegenerative risk was enriched in microglia. Thousands of expression, chromatin accessibility, and splicing quantitative trait loci revealed developmental and cell-type-specific regulatory effects. Colocalization linked multiple sclerosis risk to AHI1 expression in prenatal neurons and problematic alcohol use to GPX1 expression in postnatal glia. Leveraging dynamic cis-regulatory elements, we identified therapeutic candidates for haploinsufficient neurodevelopmental disorders, including a SOX5 enhancer whose CRISPR activation increased transcript and protein abundance. Together, these findings establish a publicly accessible genomic resource for resolving the developmental and cellular contexts of genetic risk and identifying therapeutic targets in the human brain.
Authors: Narjes Rohani, Rothem Kovner, Yuting Liu, Antonio Garcia Guerra, Theodora Markati, Soo-Whee Kim, Yujin Kim, Qi Xu, Emilie M Wigdor, Jakob Weiss, Joseph L Lalli, Shan Dong, Anandita Nadkarni, Xuran Wang, Lambertus Klei, Sirisha Pochareddy, Daniel Speckhard-Pasque, Chimmi Dema, Sandra Canosa, Hyesun Cho, Ashley Deveau-French, Gracie Gordon, Michael Griffiths, Karan Jaisingh, Joy Kachko, Pooja Kathail, Mingli Li, Dan Liang, Alicia Ljungdahl, Shaojie Ma, Ruhani Makkar, Nicholas F Page, Alexa-Nicole Sliby, Menglei Zhang, Xuefang Zhao, Homa Adle-Biassette, Chun Jimmie Ye, Harrison Brand, Michael E Talkowski, Philip L De Jager, Donna M Werling, Matthew J Girgenti, Carlo Rinaldi, Kathryn Roeder, Bernie Devlin, Nenad Sestan, Stephan J Sanders
Institutions: University of Oxford, Yale University, University of Minnesota, University of Wisconsin–Madison, University of California, San Francisco, Icahn School of Medicine at Mount Sinai, University of Pittsburgh, Pennsylvania State University, Genentech, Broad Institute, Massachusetts General Hospital, Stanley Center for Psychiatric Research, University of California, Berkeley, Center for Excellence in Brain Science and Intelligence Technology, University of Chinese Academy of Sciences, John Radcliffe Hospital, Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, NeuroDiderot, Columbia University Irving Medical Center, Carnegie Mellon University, New York Genome Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: neurodevelopmental disorders, neurodegenerative disease risk, chromatin accessibility, splicing quantitative trait loci, cis-regulatory elements, multiple sclerosis, AHI1, alcohol abuse, glutathione peroxidase 1, microglia, haploinsufficiency, CRISPR activation, therapeutic target, brain development, gene regulatory networks
Open Access status: green
OpenAlex ID: W7235369005
